Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
Provided By GlobeNewswire
Last update: Apr 29, 2025
Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune evasion by tumor cells
Read more at globenewswire.com51.35
-8.23 (-13.81%)
Find more stocks in the Stock Screener
TNXP Latest News and Analysis
